Novel anticoagulants get nod in new AF guidelines

New guidelines for managing patients with nonvalvular atrial fibrillation recommend dabigatran, rivaroxaban, and apixaban, as well as warfarin, and call on physicians to use a more comprehensive...

Field of Interest: Cardiology
Type: News Item

Ustekinumab again linked to cardiovascular events

WAIKOLOA, HAWAII – The anti-interleukin-12/23 biologic agents ustekinumab and briakinumab were associated with a statistically significant 4.23-fold increased risk of major adverse cardiac events in...

Field of Interest: Dermatology
Type: News Item

Adding HbA1c doesn’t improve CVD risk assessment

Adding hemoglobin A1c level to traditional cardiovascular risk factors doesn’t improve the prediction of incident cardiovascular disease among middle-age and older adults who don’t have...

Field of Interest: Endocrinology
Type: News Item

Corporate health care is here

Hospital mergers have been accelerating in the last few years, and doctors and other health care workers have been swept up in the process. The last time merger mania took place in the 1990s,...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness